Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.

Abstract

BACKGROUND Intramuscular (IM) injection can increase insulin absorption, causing hypoglycemia. Available needle lengths today are 4-12.7 mm for pens and 6-12.7 mm for syringes. We describe the distance (D) from skin surface to muscle fascia at injection sites for subcutaneous (SC) insulin therapy and recommend needle lengths to reduce IM injection risk… (More)
DOI: 10.1089/dia.2014.0111

Topics

5 Figures and Tables

Cite this paper

@article{Hirsch2014IntramuscularRA, title={Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.}, author={Laurence Hirsch and Karen J Byron and Michael Gibney}, journal={Diabetes technology & therapeutics}, year={2014}, volume={16 12}, pages={867-73} }